Ciliary Body and Choroid Melanoma, Small Size Completed Phase 2 Trials for Cixutumumab (DB12250)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030836 (Ciliary Body and Choroid Melanoma, Small Size) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01413191 | Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye | Treatment |